Zobrazeno 1 - 10
of 100
pro vyhledávání: '"Qi-mei Li"'
Autor:
Peng-Cheng Ma, Qi-Mei Li, Rui-Ning Li, Chang Hong, Hao Cui, Zi-Yong Zhang, Yan Li, Lu-Shan Xiao, Hong Zhu, Lin Zeng, Jun Xu, Wei-Nan Lai, Li Liu
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Background and Aims: Metabolic dysfunction-associated steatotic liver disease (MASLD) poses a considerable health risk. Nevertheless, its risk factors are not thoroughly comprehended, and the association between the reticulocyte count and MASLD remai
Externí odkaz:
https://doaj.org/article/bfcda49487ce4eb485228f03b5c32a25
Autor:
Qi-mei Li, Qing-can Sun, Yan Jian, Jing-zhe He, Hong-bo Zhu, Chang Hong, Lin Zeng, Rui-ning Li, Jia-ren Wang, Yan Li, Li-ya Chen, Xie Weng, Li Liu, Han-zhi Dong, Lu-shan Xiao, Hao Cui
Publikováno v:
Discover Oncology, Vol 14, Iss 1, Pp 1-11 (2023)
Abstract Immune checkpoint inhibitors (ICIs) are safe and efficacious treatments for advanced primary liver cancer (PLC). The efficacy of different ICIs in the treatment of liver cancer remains unclear. The purpose of this study was to explore whethe
Externí odkaz:
https://doaj.org/article/fb7d485d595a49219f09f4893d9eea3e
Autor:
Lu‐Shan Xiao, Cheng‐Yi Hu, Hao Cui, Rui‐Ning Li, Chang Hong, Qi‐Mei Li, Chao‐Yi Huang, Zhong‐Yi Dong, Hong‐Bo Zhu, Li Liu
Publikováno v:
Cancer Medicine, Vol 11, Iss 24, Pp 4880-4888 (2022)
Abstract Background & aims Immune checkpoint inhibitors (ICIs) play an increasingly important role in the treatment of primary liver cancer (PLC). Some patients with PLC experience symptoms of splenomegaly. Splenomegaly may affect the efficacy of ICI
Externí odkaz:
https://doaj.org/article/ec5ab38ac646427b8bd27ec47f9a0cc7
Autor:
Jia-Ren Wang, Rui-Ning Li, Chao-Yi Huang, Chang Hong, Qi-Mei Li, Lin Zeng, Jing-Zhe He, Cheng-Yi Hu, Hao Cui, Li Liu, Lu-Shan Xiao
Publikováno v:
Liver Research, Vol 6, Iss 3, Pp 175-180 (2022)
Background and aim: Immune checkpoint inhibitors (ICIs) are widely used in the treatment of liver cancer. However, the interaction with other drugs may change the efficacy of ICIs. Few studies investigated the effects of antibiotics (ATBs) on the eff
Externí odkaz:
https://doaj.org/article/302eb7ea5794461ab3e12b5a636539e6
Autor:
Lu-shan Xiao, Rui-ning Li, Hao Cui, Chang Hong, Chao-yi Huang, Qi-mei Li, Cheng-yi Hu, Zhong-yi Dong, Hong-bo Zhu, Li Liu
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background Immune checkpoint inhibitors (ICIs) have been used to successfully treat primary liver cancer (PLC); however, identifying modifiable patient factors associated with therapeutic benefits is challenging. Obesity is known to be assoc
Externí odkaz:
https://doaj.org/article/5feeb91dc8b64c83b53ec7be71d661de
Autor:
Qi-mei Li, Cheng-kai Wu, Peng-cheng Ma, Hao Cui, Rui-ning Li, Chang Hong, Lin Zeng, Sheng-wu Liao, Lu-shan Xiao, Li Liu, Wen-yuan Li
Publikováno v:
Lipids in Health and Disease, Vol 21, Iss 1, Pp 1-11 (2022)
Abstract Background Dyslipidemia is a significant contributor to cardiovascular and cerebrovascular diseases. Research on the relationship between breakfast consumption frequency and dyslipidemia in the working population is lacking. Therefore, we ai
Externí odkaz:
https://doaj.org/article/924548a7e7c44318b6e6f76979f22173
Autor:
Qi, Mei-li1, Wang, Wen1, Liu, Xiao-Cun1, Wang, Xiaoying1, Li, Jin1 sdzblijin@163.com, Zhang, Haijun2 zhanghaijun@tongji.edu.cn, Tonsuaadu, Kaia, Allard, Marco M., Diniz, Renata
Publikováno v:
Frontiers in Chemistry. 2024, p1-7. 7p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
In Ceramics International 1 June 2023 49(11) Part A:17148-17157
Autor:
Zhang, Mingguang, Qi, Mei-li, Yuan, Kunshan, Liu, Hanjie, Ren, Jinping, Liu, Aihua, Yao, Shengkun, Guo, Xiangrui, Li, Xiushan, Zhang, Haijun
Publikováno v:
In Journal of Materials Research and Technology January-February 2023 22:728-734